Project Grant HT9425261E484
Award Date 9/1/26
Completion Date 8/31/29
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98109, USA
Similar Awards
- The Defense Health Agency awarded the Seattle Institute For Biomedical And Clinical Research $657,123 on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to investigate air pollution exposure during military deployment and liver cancer risk among United States veterans. The award funds a three-year project period ending August 31, 2029, with work performed in Seattle, Washington. The grant is structured as a Project Grant, a form of assistance that...
- Federal Grant Award Summary Fred Hutchinson Cancer Center received a $2.112 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the four-year period from July 1, 2025 through June 30, 2029. The grant supports research titled "Prevention of Liver Metastasis by Defining Regulators of Tumor Dormancy, How They Are Disrupted, and How to Reverse It," conducted at the center's Seattle, Washington facility....
- The Defense Health Agency awarded the Seattle Institute for Biomedical and Clinical Research $1.1 million on June 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to investigate associations between military deployment and early-onset colorectal cancer mortality in veterans. The award, which represents a modification (P00001) transferring the grant from VA Connecticut Research and Education Foundation Inc., funds research activity through July 31, 2030, and is...
- The U.S. Defense Health Agency awarded a $5,149,107 Project Grant to the Fred Hutchinson Cancer Center in Seattle, WA, under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at "Defining Human Correlates of Super-Evasive Disseminated Tumor Cells, Their Pathological Relevance and How to Eradicate Them" over the period of July 1, 2025 to June 30, 2029. The research will be conducted by the prominent non-profit medical research...
- Federal Project Grant Award Summary Fred Hutchinson Cancer Center received a $525,847 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 15, 2025 through July 14, 2027. The award supports research to define and exploit essential components of the androgen receptor program operative in castration-resistant prostate cancers. This research addresses a critical health challenge affecting military...
- The Defense Health Agency awarded a $1,412,826 Project Grant on September 1, 2023 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to conduct research through the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "Identification of Risk and Early Detection Biomarkers for Liver Cancer," will support a 3-year study led by Dr. Towia Libermann at Bidmc, with a sub-award to Vanderbilt University Medical Center (VUMC) to assist with case...
- The Defense Health Agency awarded a $1,036,233 Project Grant to the Fred Hutchinson Cancer Research Center under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2021 through June 2024 to develop more precise molecular classification and targeted treatment of metastatic castration-resistant prostate cancer (MCRPC) through multi-omic analysis of circulating tumor DNA (ctDNA). By leveraging ctDNA analysis, the research aims to transform...
- The Defense Health Agency awarded Sloan-Kettering Institute For Cancer Research $1,145,096 on July 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support modeling and targeting of FH-deficient renal cell carcinoma for precision therapy. Work is performed in New York, NY, with a period of performance through June 30, 2029. The award is structured as a Project Grant, a common assistance type under this program supporting basic, applied, and advanced...
- The Defense Health Agency awarded The University of Texas MD Anderson Cancer Center $559,969 on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to fund research modulating the cAMP pathway to improve the activity of CAR-T cell therapy in kidney cancer. The award is a project grant with performance through August 31, 2028, and work performed in Houston, Texas. The Military Medical Research and Development program supports basic, applied, and advanced...
- The Defense Health Agency awarded Vanderbilt University Medical Center $1.166 million on July 31, 2026, under the Military Medical Research and Development program (CFDA 12.420) to optimize lung cancer screening guidelines for all Americans. The project runs through July 30, 2029, with performance in Nashville, Tennessee. The assistance type is a Project Grant. The program supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American...